Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center

Roy F Chemaly, Shubhra Ghosh, Gerald P Bodey, Nidhi Rohatgi, Amar Safdar, Michael J Keating, Richard E Champlin, Elizabeth A Aguilera, Jeffrey J Tarrand, Issam I Raad, Roy F Chemaly, Shubhra Ghosh, Gerald P Bodey, Nidhi Rohatgi, Amar Safdar, Michael J Keating, Richard E Champlin, Elizabeth A Aguilera, Jeffrey J Tarrand, Issam I Raad

Abstract

Community respiratory viruses (CRVs) have been recognized as a potential cause of pneumonia and death among hematopoietic stem cell transplantation (HSCT) recipients and patients with hematologic malignancies. We reviewed the Microbiology Laboratory records dated from July 1, 2000, to June 30, 2002, to identify patients who had respiratory specimens positive for influenza, parainfluenza, respiratory syncytial virus, or picornavirus. We identified 343 infections among patients with underlying hematologic malignancies and HSCT. We collected data on type of disease, age, sex, type of infection, neutrophil and lymphocyte counts, therapy, and outcome. Influenza, parainfluenza, and respiratory syncytial virus accounted for most cases and were approximately equal in frequency. Most infections occurred predominantly among recipients of allogeneic transplants. Infection progressed to pneumonia in 119 patients (35%) and occurred with similar frequency for the 3 viruses. Patients at greatest risk for developing pneumonia included those with leukemia, those aged more than 65 years, and those with severe neutropenia or lymphopenia. Lack of respiratory syncytial virus-directed antiviral therapy (p=0.025) and age (p=0.042) were associated with development of respiratory syncytial virus pneumonia, and an absolute lymphocyte count<or=200 cells/mL (p=0.049) was associated with development of influenza pneumonia. The overall mortality rate for CRV pneumonia was 15%. The only independent predictor of fatal outcome was an absolute lymphocyte count<or=200 cells/mL (p=0.03) in patients with influenza pneumonia.HSCT recipients and patients with hematologic malignancies who develop upper respiratory infection due to CRVs should be considered for antiviral therapy of proven efficacy to reduce the risk of pneumonia and death.

References

    1. Bowden RA. Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center Experience. Am J Med. 1997;102:27-30.
    1. Champlin RE, Whimbey E. Community respiratory virus infections in bone marrow transplant recipients. The M. D. Anderson Cancer Center experience. Biol Blood Marrow Transplant. 2001;7(Suppl):8S-10S.
    1. Coiras MT, Perez-Brena P, Garcia ML, Casas I. Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay. J Med Virol. 2003;69:132-144.
    1. De Vincenzo JP, Hirsch RL, Fuentes RJ, Top FH Jr. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation-a compassionate use experience. Bone Marrow Transplant. 2000;25: 161-165.
    1. Ebbert JO, Limper AH. Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome. Respiration. 2005;72:263-269.
    1. Edell D, Bruce E, Hale K, Edell D, Khoshoo V. Reduced long-term respiratory morbidity after treatment of respiratory syncytial virus bronchiolitis with ribavirin in previously healthy infants. A preliminary report. Pediatric Pulmonol. 1998;25:154-158.
    1. Englund JA, Piedra PA, Jewell A, Patel K, Baxter BB, Whimbey E. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J Clin Microbiol. 1996;34:1649-1653.
    1. Englund JA, Sullivan CJ, Jordan MC. Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med. 1988;109: 203-208.
    1. Englund JA, Whimbey E, Atmar RL. Diagnosis of respiratory viruses in cancer and transplant patients. Curr Clin Top Infect Dis. 1999;19: 30-59.
    1. Falsey AR, McCann RM, Hall W, Criddle MM. Evaluation of four methods for the diagnosis of RSV infections in immunocompromised adults. J Am Geriatr Soc. 1996;44:71-74.
    1. Fan J, Henrickson KJ, Savatski LL. Rapid simultaneous diagnosis of infections with RSV viruses A and B, influenza A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex). Clin Infect Dis. 1998;26:1397-1402.
    1. Ghosh S, Champlin R, Couch R, Englund J, Raad I, Malik S, Luna M, Whimbey E. Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis. 1999;29:528-532.
    1. Ghosh S, Champlin RE, Englund J, Giralt SA, Rolston K, Raad I, Jacobson K, Neumann J, Ippoliti C, Mallik S, Whimbey E. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant. 2000;25:751-755.
    1. Gillissen A, Hoffken G. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment. Med Microbiol Immunol. 2002;191:165-168.
    1. Hall CB, Douglas RG Jr, Geiman JM, Messner MK. Nosocomial respiratory syncytial virus infection. N Engl J Med. 1975;293:1343-1346.
    1. Hall CB, Geiman JM, Douglas RG Jr, Meagher MP. Control of nosocomial respiratory syncytial viral infections. Pediatrics. 1978;62: 728-732.
    1. Harrington RD, Hooton TM, Hackman RC, Storch GA, Osborne B, Gleaves CA, Benson A, Myers JD. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis. 1992;165:987-993.
    1. Hassan IA, Chopra R, Swindell R, Mutton JM. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie Hospital experience. Bone Marrow Transplant. 2003;32:73-77.
    1. Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, Huson L, Ward P, Mills RG. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med. 1999;341: 1336-1343.
    1. Henrickson KJ. Cost-effective use of rapid diagnostic techniques in the treatment and prevention of viral respiratory infections. Pediatr Ann. 2005;34:24-31.
    1. Hiatt JR, Gong H, Mulder DG, Ramming KP. The value of open lung biopsy in the immunosuppressed patient. Surgery. 1982;92:285-291.
    1. Hicks KL, Chemaly RF, Kontoyiannis DP. Community respiratory viruses in patients with cancer. Cancer. 2003;97:2576-2587.
    1. Hindiyeh M, Hillyard DR, Carroll KC. Evaluation of the Prodesse Hexaplex multiplex PCR assay for direct detection of seven respiratory viruses in clinical specimens. Am J Clin Pathol. 2001;116:218-224.
    1. Hohenthal U, Nikoskelainen J, Vainionpaa R, Peltonen R, Routamaa M, Itala M, Kotilainen P. Parainfluenza virus type 3 infections in a hematology unit. Bone Marrow Transplant. 2001;27:295-300.
    1. Isaacs D, Dickson H, O'Callaghan C, Sheaves R, Winter A, Moxon ER. Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Arch Dis Child. 1991;66:227-231.
    1. Kaiser L, Hayden FG. Editorial response: rhinovirus pneumonia-a clinical entity? Clin Infect Dis. 1999;29:533-555.
    1. LaRosa AM, Champlin RE, Mirza N, Gajewski J, Giralt S, Rolston KV, Raad I, Jacobson K, Kontoyiannis D, Elting L, Whimbey E. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis. 2001;32:871-876.
    1. Leclair JM, Freeman J, Sullivan BF, Crowley CM, Goldmann DA. Prevention of nosocomial respiratory virus infections through compliance with glove and gown isolation precautions. N Engl J Med. 1987;317:329-334.
    1. Lewis VA, Champlin R, Englund J, Couch R, Goodrich JM, Rolston K, Prezepiorka D, Mirza NQ, Yousuf HM, Luna M, Bodey GP, Whimbey E. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis. 1996;23:1033-1037.
    1. Lindquist SW, Darnule A, Istra A, Demmler GJ. Parainfluenza virus type 4 infections in pediatric patients. Pediatr Infect Dis J. 1997;16:34-38.
    1. Ljungman P. Prevention and treatment of viral infections in stem cell transplant recipients. Br J Haematol. 2002;118:44-57.
    1. Ljungman P, Gleaves CA, Meyers JD. Respiratory virus infection in immunocompromised patients. Bone Marrow Transplant. 1989;4:35-40.
    1. Ljungman P, Ward KN, Crooks BN, Parker A, Martino R, Shaw PJ, Brinch L, Brune M, De La Camara R, Dekker A, Pauksen K, Russell N, Schwarer AP, Cordonnier C. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2001;28:479-484.
    1. Machado CM, Vilas Boas LS, Mendes AVA, Sanstos MF, da Rocha IF, Sturaro D, Dulley FL, Pannuti CS. Low mortality rates related to respiratory virus infections after bone marrow transplantation. Bone Marrow Transplant. 2003;31:695-700.
    1. Marcolini JA, Malik S, Suki D, Whimbey E, Bodey GP. Respiratory disease due to parainfluenza virus in adult leukemia patients. Eur J Clin Microbiol Infect Dis. 2003;22:79-84.
    1. Martino R, Porras RP, Rabella N, Williams JV, Ramila E, Margall N, Labeaga R, Crowe JE Jr, Coll P, Sierra J. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant. 2005;11:781-796.
    1. Martino R, Ramila E, Rabella N, Munoz JM, Peyret M, Portos JM. Respiratory virus infection in adults with hematologic malignancies: a prospective study. Clin Infect Dis. 2003;36:1-8.
    1. McCann S, Byrne JL, Rovira M, Shaw P, Ribaud P, Sica S, Volin L, Olavarria E, Mackinnon S, Trabasso P, VanLint MT, Ljungman P, Ward K, Browne P, Gratwohl A, Widmer AF, Cordonnier C; Infectious Diseases Working Party of the EBMT. Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. Bone Marrow Transplant. 2004;33:519-529.
    1. Meyers JD, Flournoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation. Rev Infect Dis. 1982;4:1119-1132.
    1. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood. 2001;98:573-578.
    1. Nichols WG, Gooley T, Boeckh M. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center Experience. Biol Blood Marrow Transplant. 2001;7:115-155.
    1. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis. 2004;39:1300-1306.
    1. Palese P, Young JF. Variations of influenza A, B, and C viruses. Science. 1982;215:1468-1474.
    1. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The Impact-RSV Study Group. Pediatrics. 1998;102:531-537.
    1. Raboni SM, Nogueira MB, Tsuchiya LR, Takahashi GA, Pereira LA, Pasquini R, Siqueria MW. Respiratory tract viral infections in bone marrow transplant patients. Transplantation. 2003;76:142-146.
    1. Roghmann M, Ball K, Erdma D, Lovchik J, Anderson LJ, Edelman R. Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation. Bone Marrow Transplant. 2003;32:1085-1088.
    1. Small TN, Casson A, Malak SF, Boulad F, Kiehn TE, Stiles J, Ushay HM, Sepkowitz KA. Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:321-327.
    1. Snydman DR, Greer C, Meissner HC, McIntosh K. Prevention of nosocomial transmission of respiratory syncytial virus in a newborn nursery. Infect Control Hosp Epidemiol. 1988;9:105-108.
    1. Update: respiratory syncytial virus activity-United States, 1997-1998 season. MMWR Morb Mortal Wkly Rep. 1997;46:1163-1165.
    1. Weinstock DM, Eagan J, Malak SA, Rogers M, Wallace H, Kiehn TE, Sepkowitz KA. Control of influenza A on a bone marrow transplant unit. Infect Control Hosp Epidemiol. 2000;21:730-732.
    1. Wendt CH, Weisdorf DJ, Jordan MC, Balfour HH Jr, Hertz MI. Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med. 1992;326:921-926.
    1. Whimbey E, Bodey GP. Viral pneumonia in the immunocompromised adult with neoplastic disease: the role of common community respiratory viruses. Semin Respir Infect. 1992;7:122-131.
    1. Whimbey E, Champlin RE, Couch RB, Englund JA, Goodrich JM, Raad I. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis. 1996;22:778-782.
    1. Whimbey E, Elting LS, Couch RB, Lo W, Williams L, Champlin R, Bodey GP. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant. 1994;13:437-440.
    1. Whimbey E, Ghosh S. Respiratory syncytial virus infections in immunocompromised adults. Curr Clin Top Infect Dis. 2000;20:232-255.
    1. Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet. 2001;358:1410-1416.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever